Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: HOG GU12-160 Principal Investigator: Picus, Joel
Title: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum-containing Regimen
Description: The purpose of this study is to evaluate whether the combination of OGX-427 plus docetaxel will prolong the survival time of compared to docetaxel alone in patients with urothelial cancer whom are no longer responding to platinum-based chemotherapy treatment....MORE
___________________________________________________________________________________________________
 Number: RTOG 0926 Principal Investigator: Gay, Hiram
Title: A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
Description: The purpose of this study is to find out the effects of transurethal surgery followed by radiation therapy plus chemotherapy....MORE
___________________________________________________________________________________________________
 Number: NRG GU001 Principal Investigator: Michalski, Jeff
Title: Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder Cancer (NRG-GU001)
Description: You are being asked to take part in this study because you have bladder cancer that may come back after initial treatment. People who are not in a study are usually treated with surgery, sometimes with chemotherapy given either before or after the surgery. There are several FDA approved chemothera...MORE
___________________________________________________________________________________________________
 Number: CTSU S1011 Principal Investigator: Grubb, III, Robert
Title: A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed At Time of Radial Cystectomy For Muscle Invasive Urothelial Cancer
Description: The purpose of this study is to compare the effects, good and/or bad, of performing a standard lymph node removal versus an extended lymph node removal for patients with muscle invasive urothelial cancer....MORE
___________________________________________________________________________________________________
 Number: 201502056 Principal Investigator: Picus, Joel
Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of B-701 Plus Docetaxel Versus Placebo Plus Docetaxel in the Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma in Subjects who have Relapsed After, or are Refractory to Standard Therapy
Description: The purpose of this research study is to test the effectiveness and safety of an experimental drug known as B-701. The study will determine how well the drug is treats urothelial cell carcinoma and what effects, good and/or bad, it has on patients....MORE
___________________________________________________________________________________________________
 Number: 201407150 Principal Investigator: Picus, Joel
Title: An Open-Label, Single-Arm, Phase 2 Study of Mocetinostat in Selected Patients with Inactivating Alterations of Acetyltransferase Genes in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma
Description: The main purpose of this study is to test whether patients with urothelial carcinoma with specific changes in the tumor genes benefit from treatment with mocetinostat....MORE
___________________________________________________________________________________________________
 Number: 201306057 Principal Investigator: Picus, Joel
Title: A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial Cancer
Description: The main purpose is to determine a safe dose of an invesigational drug, AGS15E, by testing the drug at different dose levels. The study will find out what effects, good and/or bad, it has on patients and their cancer....MORE
___________________________________________________________________________________________________
 Number: 201411135 Principal Investigator: Arora, Vivek
Title: Tissue, Blood, and Urine Acquisition for Genomic Analysis and Collection of Health Information for Patients with Malignancies of the Genitourinary Tract
___________________________________________________________________________________________________
 Number: 201405049 Principal Investigator: Govindan, Ramaswamy
Title: A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects with Advanced or Refractory Solid Tumors or Lymphoma
Description: The purpose of this research study is to determine the effectiveness of the study drug, JNJ-42756493, on relapsed or refractory solid tumors....MORE
___________________________________________________________________________________________________